An optimized luciferin formulation for NanoLuc-based in vivo bioluminescence imaging

CFz9 with improved solubility for in vivo BLI applications

CFz (Fig. 1a) was previously developed as an improved NanoLuc substrate for non-invasive imaging in animal brains¹⁶. For repeated, longitudinal BLI applications, a standard dose of 1.3…